Help us improve Portfolio Grader.

Help us improve Portfolio Grader.

Blue Chip Growth

Stock Report: Fresenius Medical Care AG & Co. KGaA Sponsored ADR (FMS) Report Updated: Jan 19, 2015 | Print This Page

Get more stock ratings by Louis Navellier

Fresenius Medical Care AG & Co. KGaA Sponsored ADR (FMS)

Rating: Buy Volatility: Conservative
Total Grade: B Industry: Health Care Providers & Services
Competitors: CHE, AMED, HNT, BRLI
service keys

Fresenius Medical Care AG & Co. KGaA Sponsored ADR© quotemedia

Company Profile

Fresenius Medical Care AG & Co. KGaA, a kidney dialysis company, provides products and services for the treatment of end-stage renal disease worldwide. The company owns and operates dialysis clinics that provide dialysis treatment, and related laboratory and diagnostic services. As of December 31, 2011, it operated 2,898 clinics in approximately 40 countries. The company’s laboratory services comprise blood, urine, and other bodily fluid testing services. It also offers hemodialysis (HD) machines; modular components for dialysis machines; polysulfone dialyzers; bloodlines, HD solutions, concentrates, and granulates; needles; connectors; machines for water treatment; data administration systems; dialysis chairs; iron products; and other renal drug products, as well as peritoneal dialysis cycler machines and disposable products. In addition, the company also provides adsorbers, which are specialized filters used in other extracorporeal therapies; and distributes specific instruments for vascular access, as well as other supplies that include bandages, clamps, and injections. Further, it offers dialysis solutions in bags, such as solutions for priming and rinsing HD bloodlines, as well as connection systems for central concentrate supplies and devices for mixing dialysis solutions; and solutions for disinfecting and decalcifying HD machines, fistula needles, and HD catheters, as well as dialysis tubing systems and accessories. Additionally, the company provides a line of peritoneal dialysis systems and solutions, which comprise continuous ambulatory peritoneal dialysis (CAPD) and continuous cycling peritoneal dialysis systems. It also offers automated connection technology; and patient management software tools to support both CAPD and APD therapies. Fresenius Medical Care AG & Co. KGaA sells its products through local sales forces, independent distributors, dealers, and sales agents. The company was founded in 1996 and is headquartered in Bad Homburg, Germany.

Recent News: Fresenius Medical Care AG & Co. KGaA Sponsored ADR